Dr. Felippe Ottoni Marcondes, MD

Dr. Marcondes practices at Tufts Medical Center in Boston, Massachusetts, part of Tufts Medicine.

Dr. Marcondes' NPI, 1518493444, was assigned on May 11, 2017. Dr. Marcondes graduated from University of Texas Medical School at Houston in 2017. Dr. Marcondes holds Massachusetts license 282143.

Dr. Marcondes' primary practice is Tufts Medical Center, at 800 Washington Street, Boston, MA 02111 in Suffolk County. The practice phone is (617) 636-5000.

Dr. Marcondes' primary practice is Tufts Medical Center in Boston, Massachusetts, part of Tufts Medicine. Dr. Marcondes is also affiliated with Massachusetts General Hospital. The medical group on file is Massachusetts General Hospital. Dmand AI also links Dr. Marcondes to 5 more hospitals, 3 home health agencies, 2 group practices and clinics, 1 imaging center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Marcondes practices, 13 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Marcondes' primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Marcondes' licenses on file in 2 states: Massachusetts and Texas.

CMS data shows 215 Medicare services from Dr. Marcondes across 2 procedure codes in 2024, all of them office visits, for 171 Medicare patients. Medicare paid $20,262 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 171 Medicare patients who saw Dr. Marcondes in 2024. The largest group is 75 to 84, with 75 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Marcondes' median patient age at 77, with 58% women.

In 2024, Dr. Marcondes wrote 500 Medicare Part D claims for 124 patients. 92% of them were for generic drugs. CMS names the drug for 214 of them, across 12 drugs with 11 or more claims each, at $2,559 in total drug cost. In 2023, CMS named 51 claims across 3 drugs.

Dr. Marcondes accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Marcondes as offering telehealth.

Dmand AI links 15 papers to Dr. Marcondes, published from 2018 to 2024. 2024 was the busiest year, with 4. The most frequent topics are Ethnicity, Medicare and Adenoma. Dr. Marcondes has published most often in Ann Intern Med. Dr. Marcondes' most frequent co-authors are Timothy S. Krill, MD, Ronald Erastus Samuel, MD and Alisa Beth Busch, MD.

Dr. Marcondes graduated from University of Texas Medical School at Houston in 2017.